Bambusa Therapeutics

Recent Finacing

Series A II

Recent Raise

Undisclosed

Bambusa Therapeutics is a Boston-based clinical-stage biotech developing next-generation bispecific antibodies for immunology and inflammation.

Massachusetts, United States

11-50

Private

PitchBook

Highlights

Focus Areas

Biotechnology

Health Care

Life Science

Medical

Recent Investors

Financials

$105M

Total Raised

3

Funding rounds

10

Investors

Team

Upgrade to view the team

See the team members at Bambusa Therapeutics.